Summary

Eligibility
for people ages 18 years and up (full criteria)
Dates
study started
completion around
Principal Investigator
by Estelle M. Everett, MD, MHS
Headshot of Estelle M. Everett
Estelle M. Everett

Description

Summary

Diabetes technology has revolutionized T1D management, disparities in technology access are evident among racial-ethnic minorities, patients with lower socioeconomic status and those with poorly controlled T1D (A1c>9%). In order to examine whether diabetes technology can reduce diabetes care burdens and enhance outcomes among some of highest need patients, diabetes technology clinical trials must be expanded beyond the very select populations included in studies thus far (ie., mostly White, higher SES). Therefore, the investigators propose to perform a pilot RCT of hybrid closed-loop insulin pump therapy (HCL) in 40 diverse adult patients with poorly controlled T1D (HbA1c >9%) from the largest academic and safety net health systems in the Los Angeles region to determine the feasibility of a RCT in this population and identify facilitators and barriers of effective use of closed loop insulin pump therapy in patients with poorly controlled T1D.

Official Title

Starting Technology in At Risk Type 1 Diabetes (STAR-T1D) Study

Keywords

Diabetes Mellitus, Type 1, Continuous Glucose Monitoring, Insulin Pump, Hybrid Closed Loop Systems, Diabetes Technology, Health Disparities, Diabetes Mellitus, Type 1 Diabetes Mellitus, Insulin, Hybrid Closed Loop Insulin Pump System

Eligibility

You can join if…

Open to people ages 18 years and up

  • Not insulin pump user
  • Primary language of English or Spanish
  • Have medical insurance coverage

You CAN'T join if...

  • Not seen by endocrinology at least once in the past 12 months
  • No measured A1c in the past year
  • Have comorbidities that can result in inaccurate hemoglobin A1c
  • Have cognitive, physical or mental impairment precluding diabetes technology use
  • Limited life expectancy (<1 year)
  • Pregnancy

Lead Scientist at UCLA

  • Estelle M. Everett, MD, MHS
    Estelle Everett is an endocrinologist and health services researcher at Geffen School of Medicine at UCLA. She completed medical school at UCLA and then went on to Johns Hopkins to complete her internal medicine residency and endocrinology fellowship.

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Los Angeles
ID
NCT06453928
Study Type
Interventional
Participants
Expecting 40 study participants
Last Updated